MedPath

Examination of Blood Dynamics after Single Intake of MH001 in Elderly Subjects.

Not Applicable
Conditions
o
Registration Number
JPRN-UMIN000052631
Lead Sponsor
TES Holdings Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
Male
Target Recruitment
14
Inclusion Criteria

Not provided

Exclusion Criteria

[1] Individuals who have taken medicines that may affect the study for one month prior to the pre-study, and who are unable to restrict their intake from the pre-study to the end of the study (excluding those with history of per-request medication such as headache medicine and cold medicine). [2] Individuals who are patient or have a history of psychiatric disease, sleep disorder, high blood pressure, diabetes and hyperlipidemia. [3] Individuals who have a history of serious hepatopathy, kidney damage, heart disease, lung disease and hematological disease. [4] Individuals who are a patient or have a history of or gastrointestinal disease. [5] Individuals with serious anemia [6] Individuals whose BMI is less than 18.5 kg/m2 and over 25.0 kg/m2. [7] Individuals who donated blood over 200 mL in the past 1 month or over 400 mL in the past 3 months. [8] Individuals who have and had a habit to ingest food with functional claims, health foods, or supplements in the past 1 month or will ingest those foods during the test period (from screening to the observation period II). [9] Individuals who experienced unpleasant feeling during blood drawing. [10] Individuals who are sensitive to the test food. [11] Smokers or individuals who have quit smoking for less than 6 months. [12] Individuals who excessively take alcohol (expressed in an amount of alcohol: over 30g/day). [13] Individuals who participated in other clinical studies in the past 1 month. [14] Individuals judged inappropriate for the study by the principal.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath